NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Deep Brain Stimulation for Patients With Parkinson's Disease.
Deep Brain Stimulation for Patients With Parkinson's Disease.

NCT03128567

CompletedN/A

Sponsor: Institut National de la Santé Et de la Recherche Médicale, France

Conditions: Parkinson Disease

Interventions: Stimulation of the subthalamic nucleus

Countries: France

Deep brain stimulation of the sub thalamic nucleus (STN-DBS) is an efficient treatment to improve motor and non motor signs of Parkinson's disease (PD). In people aged more 70 years, an increased rate of side effects such as post-operative cognitive decline and/or postural instability with falls has been suspected with less improvement in the quality of life. Here, Investigators aim further explore the effects of STN-DBS in 50 patients with PD people aged more 69 years in a randomized parallel controlled study.

Eligibility overview

Sex: ALL

Age: 69 Years to 75 Years

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria
Inclusion Criteria:

* Parkinson's disease
* disease duration \> 5 years
* levodopa related motor complications
* dopasensitivity \> 50%
* signed informed written consent
* medical social insurance

Exclusion Criteria:

* dementia
* contra-indication to neurosurgery
Locations (7)
  • Bordeaux, France
  • Lille, France
  • Lyon, France
  • Paris, France
  • Poitiers, France
  • Rouen, France
  • Toulouse, France